| The Hospice Of Baton Rouge 9063 Siegen Lane, Suite A, Baton Rouge, LA, 70810 | |
| (225) 767-4673 |
News Archive
Researchers in Italy have demonstrated the efficacy of using modified outer membrane vesicles (OMVs) as a vaccine to protect against coronavirus disease 2019 (COVID-19) in an animal model.
Oral multikinase inhibitor regorafenib achieves significantly improved survival rates compared to placebo in patients with hepatocellular carcinoma, according to data from the phase III RESORCE trial, presented at the ESMO 18th World Congress of Gastrointestinal Cancer in Barcelona, Spain.
A recent survey on the mental health conditions of the flying in workers has shown that nearly a quarter have high to very high levels of psychological distress. The levels were found to be two and half times greater among FIFO workers when compared to the other working populations in Australia aged between 25 and 34 years.
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.
› Verified 1 days ago
| Name | The Hospice Of Baton Rouge |
|---|---|
| Location | 9063 Siegen Lane, Suite A, Baton Rouge, Louisiana |
| Hospice ID | 191507 |
| Category | Freestanding Hospice |
| Ownership Type | Voluntary Non-profit - Other |
| Profit Type | NON-PROFIT |
| Accreditation Provider | Community Health Accreditation Partner (CHAP) |
| SSA county code | 160 |
News Archive
Researchers in Italy have demonstrated the efficacy of using modified outer membrane vesicles (OMVs) as a vaccine to protect against coronavirus disease 2019 (COVID-19) in an animal model.
Oral multikinase inhibitor regorafenib achieves significantly improved survival rates compared to placebo in patients with hepatocellular carcinoma, according to data from the phase III RESORCE trial, presented at the ESMO 18th World Congress of Gastrointestinal Cancer in Barcelona, Spain.
A recent survey on the mental health conditions of the flying in workers has shown that nearly a quarter have high to very high levels of psychological distress. The levels were found to be two and half times greater among FIFO workers when compared to the other working populations in Australia aged between 25 and 34 years.
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.
› Verified 1 days ago
| NPI Number | 1689642589 |
| Organization Name | Hospice Foundation Of Greater Baton Rouge |
| Address | 3600 Florida Blvd Baton Rouge, Louisiana, 70806 |
| Phone Number | (225) 767-4673 |
News Archive
Researchers in Italy have demonstrated the efficacy of using modified outer membrane vesicles (OMVs) as a vaccine to protect against coronavirus disease 2019 (COVID-19) in an animal model.
Oral multikinase inhibitor regorafenib achieves significantly improved survival rates compared to placebo in patients with hepatocellular carcinoma, according to data from the phase III RESORCE trial, presented at the ESMO 18th World Congress of Gastrointestinal Cancer in Barcelona, Spain.
A recent survey on the mental health conditions of the flying in workers has shown that nearly a quarter have high to very high levels of psychological distress. The levels were found to be two and half times greater among FIFO workers when compared to the other working populations in Australia aged between 25 and 34 years.
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.
› Verified 1 days ago
| NPI Number | 1932627338 |
| Organization Name | Hospice Foundation Of Greater Baton Rouge |
| Address | 3600 Florida Boulevard Baton Rouge, Louisiana, 70806 |
| Phone Number | (225) 767-4673 |
News Archive
Researchers in Italy have demonstrated the efficacy of using modified outer membrane vesicles (OMVs) as a vaccine to protect against coronavirus disease 2019 (COVID-19) in an animal model.
Oral multikinase inhibitor regorafenib achieves significantly improved survival rates compared to placebo in patients with hepatocellular carcinoma, according to data from the phase III RESORCE trial, presented at the ESMO 18th World Congress of Gastrointestinal Cancer in Barcelona, Spain.
A recent survey on the mental health conditions of the flying in workers has shown that nearly a quarter have high to very high levels of psychological distress. The levels were found to be two and half times greater among FIFO workers when compared to the other working populations in Australia aged between 25 and 34 years.
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.
› Verified 1 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.3 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 96.6 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 96.9 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 48.0 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 99.5 | 97.3 |
| Patients who got timely treatment for shortness of breath | 99.0 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 94.5 | 93.3 |
News Archive
Researchers in Italy have demonstrated the efficacy of using modified outer membrane vesicles (OMVs) as a vaccine to protect against coronavirus disease 2019 (COVID-19) in an animal model.
Oral multikinase inhibitor regorafenib achieves significantly improved survival rates compared to placebo in patients with hepatocellular carcinoma, according to data from the phase III RESORCE trial, presented at the ESMO 18th World Congress of Gastrointestinal Cancer in Barcelona, Spain.
A recent survey on the mental health conditions of the flying in workers has shown that nearly a quarter have high to very high levels of psychological distress. The levels were found to be two and half times greater among FIFO workers when compared to the other working populations in Australia aged between 25 and 34 years.
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.
› Verified 1 days ago
| Home Health Aides | 14 |
| Counselors | 4 |
| Licensed Practical or Vocational Nurses | 6 |
| Medical Social Workers | 6 |
| Physicians | 2 |
| Registered Nurses | 19 |
| Total Employees | 51 |
|---|
News Archive
Researchers in Italy have demonstrated the efficacy of using modified outer membrane vesicles (OMVs) as a vaccine to protect against coronavirus disease 2019 (COVID-19) in an animal model.
Oral multikinase inhibitor regorafenib achieves significantly improved survival rates compared to placebo in patients with hepatocellular carcinoma, according to data from the phase III RESORCE trial, presented at the ESMO 18th World Congress of Gastrointestinal Cancer in Barcelona, Spain.
A recent survey on the mental health conditions of the flying in workers has shown that nearly a quarter have high to very high levels of psychological distress. The levels were found to be two and half times greater among FIFO workers when compared to the other working populations in Australia aged between 25 and 34 years.
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.
› Verified 1 days ago
| Others | 35 |
| Total Volunteers | 35 |
|---|
News Archive
Researchers in Italy have demonstrated the efficacy of using modified outer membrane vesicles (OMVs) as a vaccine to protect against coronavirus disease 2019 (COVID-19) in an animal model.
Oral multikinase inhibitor regorafenib achieves significantly improved survival rates compared to placebo in patients with hepatocellular carcinoma, according to data from the phase III RESORCE trial, presented at the ESMO 18th World Congress of Gastrointestinal Cancer in Barcelona, Spain.
A recent survey on the mental health conditions of the flying in workers has shown that nearly a quarter have high to very high levels of psychological distress. The levels were found to be two and half times greater among FIFO workers when compared to the other working populations in Australia aged between 25 and 34 years.
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.
› Verified 1 days ago
| The Hospice Of Baton Rouge Location: 9063 Siegen Lane, Suite A, Baton Rouge, Louisiana, 70810 Phone: (225) 767-4673 |
| Bridgeway Healthcare & Hospice Location: 13702 Coursey Blvd Bldg 5, Ste B, Baton Rouge, Louisiana, 70817 Phone: (225) 767-4673 |
| St Joseph Hospice, Llc Location: 10615 Jefferson Highway, Baton Rouge, Louisiana, 70809 Phone: (225) 767-4673 |
| Hospice In His Care, Llc Location: 3233 S Sherwood Forest Blvd Suite 102, Baton Rouge, Louisiana, 70816 Phone: (225) 767-4673 |